Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/TAKEDA-PHARMACEUTICAL-COM-6491073/news/Takeda-Intends-to-Rapidly-Initiate-the-First-Global-Phase-3-Trials-of-TAK-861-an-Oral-Orexin-Agonis-45918179/?utm_source=whatsapp&utm_medium=social&utm_campaign=share